According to the invention, there is provided novel hemp Cannabis cultivars with THC content of 0.2% by dry weight and a unique terpene profile. The cultivars exhibit increased CBD content of greater than about 1.07% by weight. The plants also have increased plant height and decreased branching that allows for increased yields of hemp and CBD content per acre. This invention thus relates to the seeds of hemp Cannabis cultivars of the invention, to the plants of hemp Cannabis cultivars of the invention, to plant parts of hemp Cannabis cultivars of the invention, to methods for producing a Cannabis cultivar by crossing the hemp Cannabis cultivars of the invention with another Cannabis cultivar, and to methods for producing a Cannabis cultivar containing in its genetic material one or more backcross conversion traits or transgenes and to the backcross conversion Cannabis plants and plant parts produced by those methods.

A topical pain relief composition has a base with a mixture of various components such as, but not limited to, a base, d-limonene, cannabinoids or a derivative thereof, ashwagandha extracts and dimethyl sulfoxide (DMSO).

Extraction devices and related methods are disclosed. Extraction devices disclosed may include a hopper, a piston, and an evaporation chamber. The hopper may be filled with a plant material and a solvent. The piston may be removably housed within the hopper so as to form a hermetic seal with the hopper. Once a solvent and extract mixture is formed within the hopper, a valve in the bottom of the hopper may be opened to allow the solvent and extract mixture to flow into the evaporation chamber via gravity. The remaining plant material may be compressed by the piston to remove any remaining solvent and extract mixture. The solvent may be evaporated in the evaporation chamber leaving a purified plant extract. Various types of plant materials may be used within the hopper. Various types of solvents may be used as well, including heptane and hexane.

Described is a cannabinoid-terpenoid solution (CTS) and method of treating a disease state or condition in animals other than humans via cannabinoid-terpenoid therapy. The CTS includes a unique combination of cannabinoids, terpenoids (terpenes), and a lipophilic carrier to allow safely and effectively treat the animal.

Solid compositions including a plurality of cannabinoids and methods of preparing such solid compositions are provided. The plurality of cannabinoids in the solid compositions are characterized by a chemical signature which is substantially identical to the chemical signature of cannabinoids in an extract of the Cannabis plant thereby exerting the entourage effect.

The present disclosure is directed to whole spectrum cannabinoids infused coffee beans or raw nuts and methods of producing the cannabinoids infused coffee beans or raw nuts. The coffee beans or raw nuts are infused in an overall two-step process, in which cannabinoids from a Cannabis species are first infused into coconut oil, which in turn is used to infuse coffee beans or raw nuts with cannabinoids to generate the cannabinoids infused coffee beans or raw nuts.

The present invention relates to a preparation method of non-ester tea polyphenols rich in EGC. Wall-broken crushed tea leaves are subjected to leaching using endogenous hydrolytic enzymes contained in the tea leaves. The leached solution after filtration and concentration is subjected to refining and purification by mobile leaching-water washing. The purified product is subjected to concentration and drying to obtain a non-ester tea polyphenols product rich in EGC, wherein the content of tea polyphenols is 90-99.5%, the content of EGC is greater than 80%, and the content of ester catechins EGCG+ECG is less than 10%. According to the preparation method of the non-ester tea polyphenols rich in EGC of the present invention, it does not add any exogenous hydrolytic enzyme, so as to avoid the contamination to the product by the exogenous hydrolytic enzyme. Meanwhile, the content of EGC is high, the production process is simplified, and the yield of the product is high, which is conducive to industrial production.

The present invention relates to a process for producing ethyl esters of polyunsaturated fatty acids, comprising transesterifying triacylglycerols in extracted plant lipid.

Provided is a process for extraction of a lipophilic agent from a plant source, the process including: mixing a first quantity of a plant source, the plant source being containing the lipophilic agent and a first quantity of an extraction medium to obtain a first mixture, the extraction medium being in the form of a microemulsion and comprising at least one oil, at least one hydrophilic surfactant, at least one co-surfactant and optionally at least one co-solvent; homogenizing the first mixture under conditions maintaining the microemulsion structure; and separating the homogenized mixture into a biomass slurry and an agent-loaded medium to obtain the agent-loaded medium in a microemulsion form.

The present description relates to a method for extracting at least one substance of interest, the method comprising the following steps: —providing an admixture comprising water, a source comprising the at least one substance of interest or at least one precursor thereof, at least one surfactant and at least one lipophilic compound; —the emulsification of the admixture, leading to the formation of an emulsion; wherein the emulsion comprises: —a continuous aqueous phase; and a discontinuous lipidic phase comprising the at least one lipophilic compound, the at least one surfactant and at least one substance of interest extracted from the source during the emulsification; wherein the method further comprises the addition of at least one cryoprotectant to the admixture and the lyophilisation of the emulsion.